Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase β/ζ

International Journal of Cancer

Volumn 124, Issue 8, 2009, Pages 1785-1793

  Polytarchou, Christos ^a,b   Hatziapostolou, Maria ^a,b   Poimenidi, Evangelia ^a   Mikelis, Constantinos ^a   Papadopoulou, Ariadni ^a   Parthymou, Anastasia ^a   Papadimitriou, Evangelia ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Endothelial cells; Migration; Nitric oxide; Pleiotrophin; Prostate cancer cells

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GUANYLATE CYCLASE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PLEIOTROPHIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE BETA; PROTEIN TYROSINE PHOSPHATASE ZETA; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; CARRIER PROTEIN; CYTOKINE; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; UPREGULATION; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL LINE; CELL MOTION; GENE EXPRESSION REGULATION; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

CARRIER PROTEINS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CYTOKINES; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANYLATE CYCLASE; HUMANS; MALE; MODELS, BIOLOGICAL; NITRIC OXIDE; PROSTATIC NEOPLASMS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5;

EID: 62449267453     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24084     Document Type: Article

References (47)

1. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumor progression. Nat Rev Cancer 2006;6:521-534 (Pubitemid 43980541)
2. Ying L, Hofseth LJ. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res 2007;67:1407-1410 (Pubitemid 46383362)
3. Gratton JP, Lin MI, Yu J, Weiss ED, Jiang ZL, Fairchild TA, Iwakiri Y, Groszmann R, Claffey KP, Cheng YC, Sessa WC. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell 2003;4:31-39 (Pubitemid 36904159)
4. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998;101:2567-2578 (Pubitemid 28270451)
5. Polytarchou C, Papadimitriou E. Antioxidants inhibit angiogenesis in vivo through down-regulation of nitric oxide synthase expression and activity. Free Radic Res 2004;38:501-508 (Pubitemid 38618372)
6. Polytarchou C, Papadimitriou E. Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity. Eur J Pharmacol 2005;510:31-38 (Pubitemid 40312387)
7. Zhang R, Wang L, Zhang L, Chen J, Zhu Z, Zhang Z, Chopp M. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ Res 2003;92:308-313 (Pubitemid 36258553)
8. Pyriochou A, Beis D, Koika V, Potytarchou C, Papadimitriou E, Zhou Z, Papapetropoulos A. Soluble guanylyl cyclase activation promotes angiogenesis. J Pharmacol Exp Ther 2006;319:663-671
9. Pyriochou A, Zhou Z, Koika V, Petrou C, Cordopatis P, Sessa WC, Papapetropoulos A. The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway. J Cell Physiol 2007;211:197-204. (Pubitemid 46363910)
10. Papadimitriou E, Polykratis A, Hatziapostolou M, Parthymou A, Polytarchou C, Mikelis C. Heparin affin regulatory peptide: a new target for tumor therapy? Curr Cancer Drug Targets 2004;4:471-482
11. Mikelis C, Koutsioumpa M, Papadimitriou E. Pleiotrophin as a possible new target for angiogenesis-related diseases and cancer. Recent Patents Anticancer Drug Discov 2007;2:175-186 (Pubitemid 46957318)
12. Polytarchou C, Hatziapostolou M, Papadimitriou E. Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J Biol Chem 2005;280:40428-40435 (Pubitemid 41780529)
13. Hatziapostolou M, Polytarchou C, Katsoris P, Courty J, Papadimitriou E. Heparin affin regulatory peptide/pleiotrophin mediates fibroblast growth factor 2 stimulating effects on human prostate cancer cells. J Biol Chem 2006;281:32217-32226 (Pubitemid 46036776)
14. Hatziapostolou M, Delbe J, Katsoris P, Polytarchou C, Courty J, Papadimitriou E. Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity. Prostate 2005;65:151-158 (Pubitemid 41362282)
15. Polykratis A, Katsoris P, Courty J, Papadimitriou E. Characterization of heparin affin regulatory peptide signaling in human endothelial cells. J Biol Chem 2005;280:22454-22461 (Pubitemid 40827901)
16. Kalivendi SV, Kotamraju S, Zhao H, Joseph J, Kalyanaraman B. Doxorubicin- induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium. J Biol Chem 2001;276:47266-47276
17. Tong X, Li H. eNOS protects prostate cancer cells from TRAIL-induced apoptosis. Cancer Lett 2004;210:63-71. (Pubitemid 38692589)
18. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003;3:859-868 (Pubitemid 37383716)
19. Kim DK, Cho ES, Seong JK, Um HD. Adaptive concentrations of hydrogen peroxide suppress cell death by blocking the activation of SAPK/JNK pathway. J Cell Sci 2001;114:4329-4334 (Pubitemid 33138669)
20. Crossthwaite AJ, Hasan S, Williams RJ. Hydrogen peroxide-mediated phosphorylation of ERK1/2, Akt/PKB, and JNK in cortical neurones: dependence on. Ca(21) and PI3-kinase. J Neurochem 2002;80:24-35.
21. Segarra J, Balenci L, Drenth T, Maina F, Lamballe F. Combined signaling through ERK, PI3K/AKT, and RAC1/p38 is required for Met-triggered cortical neuron migration. J Biol Chem 2006;281:4771-4778 (Pubitemid 43847738)
22. Thakali K, Davenport L, Fink GD, Watts SW. Cyclooxygenase, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase MAPK. Rho kinase, and Src mediate hydrogen peroxide-induced contraction of rat thoracic aorta and vena cava. J Pharmacol Exp Ther 2007;320:236-243
23. Anter E, Chen K, Shapira OM, Karas RH, Keaney JF Jr. p38 Mitogen- activated protein kinase activates eNOS in endothelial cells by an estrogen receptor-dependent pathway in response to black tea polyphenols. Circ Res 2005;96:1072-1078 (Pubitemid 40791379)
24. Jadeski LC, Chakraborty C, Lala PK. Nitric oxide-mediated promotion of mammary tumor cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int J Cancer 2003;106:496-504. (Pubitemid 36966204)
25. Rabkin SW, Tsang MY. The action of nitric oxide to enhance cell survival is mediated through a cGMP and ERK 1,2 pathway while p38 mitogen activated protein kinase dependent pathways do not alter cell death. Exp Physiol 2008;93:834-842
26. Thomas SR, Chen K, Keaney JF Jr. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem 2002;277:6017-6024
27. Tanaka T, Nakamura H, Yodoi J, Bloom ET. Redox regulation of the signaling pathways leading to eNOS phosphorylation. Free Radic Biol Med 2005;38:1231-1242 (Pubitemid 40445540)
28. Li G, Hu Y, Huo Y, Liu M, Freeman D, Gao J, Liu X, Wu DC, Wu H. PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin. J Biol Chem 2006;281:10663-10668 (Pubitemid 43855487)
29. Papadimitriou E, Polykratis A, Courty J, Koolwijk P, Heroult M, Katsoris P. HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides. Biochem Biophys Res Commun 2001;282:306-313 (Pubitemid 32924380)
30. Chen Z, Joshi S, Kauser K, Brooks AR. Knockdown of endothelial NOS by lentivirus-mediated short hairpin RNA in hemangioendothelioma cells increases proliferation and tumor formation. Nitric Oxide 2007;16:403-412 (Pubitemid 46843607)
31. Zhao X, Mohaupt M, Jiang J, Liu S, Li B, Qin Z. Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis. Cancer Res 2007;67:4443-4450 (Pubitemid 46815094)
32. Calvet L, Geoerger B, Regairaz M, Opolon P, Machet L, Morizet J, Joseph JM, Elie N, Vassal G. Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan. Oncogene 2006;25:3150-3159 (Pubitemid 43881556)
33. Ribatti D, Nico B, Pezzolo A, Vacca A, Meazza R, Cinti R, Carlini B, Parodi F, Pistoia V, Corrias MV. Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumor-derived interferon-gamma. Br J Cancer 2006;94:1845-1852. (Pubitemid 43882575)
34. Yamakawa T, Kurosawa N, Kadomatsu K, Matsui T, Itoh K, Maeda N, Noda M, Muramatsu T. Levels of expression of pleiotrophin and protein tyrosine phosphatase zeta are decreased in human colorectal cancers. Cancer Lett 1999;135:91-96
35. Yu JX, Cui L, Zhang QY, Chen H, Ji P, Wei HJ, Ma HY. Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis. World J Gastroenterol 2006;12:4660-4664 (Pubitemid 44269724)
36. Millet A, Bettaieb A, Renaud F, Prevotat L, Hammann A, Solary E, Mignotte B, Jeannin JF. Influence of the nitric oxide donor glyceryl trinitrate on apoptotic pathways in human colon cancer cells. Gastroenterology 2002;123:235-246 (Pubitemid 34747544)
37. Jeon HK, Choi SU, Jung NP. Association of the ERK1/2 and p38 kinase pathways with nitric oxide-induced apoptosis and cell cycle arrest in colon cancer cells. Cell Biol Toxicol 2005;21:115-125 (Pubitemid 41253204)
38. Haider AS, Peters SB, Kaporis H, Cardinale I, Fei J, Ott J, Blumenberg M, Bowcock AM, Krueger JG, Carucci JA. Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol 2006;126:869-881
39. Liu R, Oberley TD, Oberley LW. Effects of endothelial nitric oxide synthase gene expression on the tumor biology of human oral carcinoma SCC-25 cells. Cell Growth Differ 1998;9:239-246 (Pubitemid 28354304)
40. Corbley MJ. Transformation by Ras suppresses expression of the neurotrophic growth factor pleiotrophin. J Biol Chem 1997;272:24696-24702 (Pubitemid 27418689)
41. Merenmies J. Cell density-dependent expression of heparin-binding growth associated molecule (HB-GAM, p18) and its down-regulation by fibroblast growth factors. FEBS 1992;307:297-300.
42. Kondrikov D, Han HR, Block ER, Su Y. Growth and density-dependent regulation of NO synthase by the actin cytoskeleton in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2006;290:L41-50.
43. Govers R, Bevers L, de Bree P, Rabelink TJ. Endothelial nitric oxide synthase activity is linked to its presence at cell-cell contacts. Biochem J 2002;361:193-201. (Pubitemid 34174486)
44. Whitney JA, German Z, Sherman TS, Yuhanna IS, Shaul PW. Cell growth modulates nitric oxide synthase expression in fetal pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2000;278:L131-8. (Pubitemid 30104184)
45. Heiss C, Wong ML, Block VI, Lao D, Real WM, Yeghiazarians Y, Lee RJ, Springer ML. Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells. J Cell Physiol 2008;215:366-373
46. Souttou B, Raulais D, Vigny M. Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways. J Cell Physiol 2001;187:59-64. (Pubitemid 32195245)
47. Pufe T, Groth G, Goldring MB, Tillmann B, Mentlein R. Effects of pleiotrophin, a heparin-binding growth factor, on human primary and immortalized chondrocytes. Osteoarthritis Cartilage 2007;15:155-162 (Pubitemid 46132101)